Buprenorphine Treatment Centers in Pennsylvania

Pennsylvania recorded 4,757 drug overdose deaths in 2023 — a 37.1-per-100,000 age-adjusted rate that placed the state in the top fifteen for mortality. Pennsylvania has invested heavily in MAT coordination through its Opioid Use Disorder Centers of Excellence (COE) network: 45+ COEs across the state coordinate MAT, case management, and warm-handoff to community providers, prioritizing pregnant women and overdose survivors. NWVCIL's directory tracks 310 buprenorphine providers in Pennsylvania, with 38 in Philadelphia, 18 in Pittsburgh, and 11 in Erie. Pennsylvania Medical Assistance (PA MA) covers methadone, buprenorphine, and naltrexone without prior authorization, and the Department of Drug and Alcohol Programs (DDAP) licenses 71 SAMHSA-certified Narcotic Treatment Programs. 409 of the 479 verified facilities in our directory accept Medicaid, and 393 offer telehealth. PA Get Help Now (1-800-662-4357) is the state's referral line for treatment placement. For a Pennsylvanian starting buprenorphine, common pathways include: calling PA Get Help Now for warm-handoff to a COE or NTP intake, a private MAT clinic in Philadelphia, Pittsburgh, Allentown, Scranton, or Erie, a community mental-health/intellectual disability program (the state has 51 county MH/ID administrators), a Federally Qualified Health Center for PA MA or sliding-fee patients, or a telehealth visit with a Pennsylvania-licensed prescriber. Most providers can prescribe Suboxone, Subutex, Zubsolv, or the monthly Sublocade injection. SAMHSA's national helpline (1-800-662-4357) and the 988 Suicide and Crisis Lifeline are available 24/7.